Oxacillin sodium salt CAS:1173-88-2

Oxacillin sodium salt is indicated for the treatment of infections caused by penicillinase-producing staphylococci, particularly Staphylococcus aureus. It is commonly used in hospitals and healthcare facilities for the management of skin and soft tissue infections, including cellulitis, abscesses, and wound infections, where methicillin-resistant Staphylococcus aureus (MRSA) may be a concern. In cases of septicemia, endocarditis, osteomyelitis, and respiratory tract infections caused by penicillinase-producing staphylococci, oxacillin serves as an important therapeutic option for combating these serious bacterial infections. Its narrow spectrum of activity against specific pathogens makes it a preferred choice when targeting penicillinase-resistant staphylococci. Adverse effects associated with oxacillin therapy are similar to those of other penicillin antibiotics and may include hypersensitivity reactions, gastrointestinal disturbances, and rare but severe adverse reactions such as anaphylaxis. Patients with known allergies to penicillins should avoid oxacillin and be prescribed alternative antibiotics under the guidance of healthcare professionals. Proper dosing, monitoring for therapeutic efficacy, and susceptibility testing are essential components of using oxacillin effectively to ensure adequate treatment of infections and prevent the development of resistance. Collaborative efforts between healthcare providers, microbiologists, and infectious disease specialists are crucial for optimizing the use of oxacillin and promoting patient safety in the management of penicillinase-producing staphylococcal infections.